News

News
Other news

Amgen to Acquire Rodeo Therapeutics Corporation

Read full story

Infinite Looks Announces $4.2M Series A Funding to Champion the Active Textured Hair Community Through its Brand Sunday II Sunday

Read full story
Other news

On Target Laboratories Secures $21 Million for Development and Commercialization of Pafolacianine Sodium Injection

Read full story
Other news

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Read full story
Other news

Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million

Read full story
Other news

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use

Read full story
Other news

TechsoMed Raises $7 Million Series B financing led by Axil Capital

Read full story
Other news

ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes

Read full story
Partner news

OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing

Read full story
Partner news

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Read full story
Other news

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story
JNJ Press releases

Big Pharma’s Billion-Dollar Scramble to Invest in Start-ups to Fuel Innovation

Read full story
Partner news

Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis

Read full story
JNJ Press releases

Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides‐type cutaneous T‐cell lymphoma, a rare type of skin cancer

Read full story
In the media

What J&J gets out of JLABS incubators

Read full story